Silence Therapeutics develops siRNA medicines that switch off disease-linked genes, with candidates for blood, heart and obesity conditions. It last closed at $19.81 on Nov 20, up 0.00% on the day. The next earnings report for SLN is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, SLN reported EPS of -$0.08 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 6.6% the session after earnings.
AI Auto Pilots
Is SLN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SLN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SLNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SLN · as of the Nov 20 close · updated each morning
Uptrend, overbought
The stock is 0% above its 20 day and 23% above its 50 day average. It is 49% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 78), overbought. The nearest support is the Pivot S1 at $19.80, and the nearest resistance the Pivot R1 at $19.83.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 1.4%/day
Key levels
$19.8652 week high+0.3%
$19.86Swing high (Nov 13)+0.3%
$19.83Pivot R1+0.1%
$19.81Pivot+0.0%
$19.81Last close
$19.80Pivot S1−0.1%
$19.7820 day average−0.2%
$19.70Swing low (Nov 9)−0.6%
$15.2850 day average−22.9%
$13.78100 day average−30.4%
$10.16200 day average−48.7%
$4.1952 week low−78.8%
Indicators
RSI (14)
77.56
Overbought above 70
Overbought
MACD
1.20
Below its signal line
Bearish
Stochastic
73.1
Middle of its range
Neutral
ADX (14)
58.1
Strong uptrend
Williams %R
-29.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
101.2
Oversold below −100, overbought above 100
Overbought
Rate of change
+0.4%
Change over 10 sessions
Bullish
ATR (14)
$0.28
Typical daily range, 1.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 8.8%/day
Key levels
$19.8652 week high+0.3%
$19.86Swing high (Nov 13)+0.3%
$19.83Pivot R1+0.1%
$19.81Pivot+0.0%
$19.81Last close
$19.80Pivot S1−0.1%
$19.7820 day average−0.2%
$19.70Swing low (Nov 9)−0.6%
$15.2850 day average−22.9%
$13.78100 day average−30.4%
$10.16200 day average−48.7%
$4.1952 week low−78.8%
Indicators
RSI (14)
71.77
Overbought above 70
Overbought
MACD
2.79
Above its signal line
Bullish
Stochastic
99.3
Near the top of its range
Overbought
ADX (14)
39.3
Trending up
Williams %R
-0.5
Oversold below −80, overbought above −20
Overbought
CCI (20)
127.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+52.1%
Change over 10 sessions
Bullish
ATR (14)
$1.74
Typical daily range, 8.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for SLN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SLN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SLNHow many large options trades hit SLN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SLN in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SLN is in one of them and how their past SLN trades turned out.
Silence Therapeutics is a biotechnology company based in London that develops small interfering RNA, or siRNA, medicines. These molecules work by switching off specific genes linked to disease in the liver, which lowers the proteins those genes produce. Its candidates target rare blood disorders, heart and cholesterol conditions, and obesity. The company is also seeking outside partners to help take some of these treatments further.